- Home
- AORT vs WT Comparison
AORT vs WT Comparison
Compare AORT & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AORT
- WT
- Stock Information
- Founded
- AORT 1984
- WT 1985
- Country
- AORT United States
- WT United States
- Employees
- AORT N/A
- WT N/A
- Industry
- AORT Medical/Dental Instruments
- WT Investment Bankers/Brokers/Service
- Sector
- AORT Health Care
- WT Finance
- Exchange
- AORT Nasdaq
- WT Nasdaq
- Market Cap
- AORT 1.9B
- WT 1.9B
- IPO Year
- AORT 1993
- WT N/A
- Fundamental
- Price
- AORT $43.37
- WT $13.61
- Analyst Decision
- AORT Strong Buy
- WT Buy
- Analyst Count
- AORT 5
- WT 5
- Target Price
- AORT $40.00
- WT $12.48
- AVG Volume (30 Days)
- AORT 469.4K
- WT 3.1M
- Earning Date
- AORT 08-07-2025
- WT 07-31-2025
- Dividend Yield
- AORT N/A
- WT 0.88%
- EPS Growth
- AORT N/A
- WT N/A
- EPS
- AORT N/A
- WT 0.40
- Revenue
- AORT $405,037,000.00
- WT $444,568,000.00
- Revenue This Year
- AORT $12.20
- WT $11.62
- Revenue Next Year
- AORT $10.63
- WT $10.76
- P/E Ratio
- AORT N/A
- WT $33.56
- Revenue Growth
- AORT 7.44
- WT 15.43
- 52 Week Low
- AORT $21.97
- WT $7.47
- 52 Week High
- AORT $43.85
- WT $13.79
- Technical
- Relative Strength Index (RSI)
- AORT 84.01
- WT 65.51
- Support Level
- AORT $30.27
- WT $11.64
- Resistance Level
- AORT $43.91
- WT $13.79
- Average True Range (ATR)
- AORT 1.25
- WT 0.30
- MACD
- AORT 1.36
- WT -0.05
- Stochastic Oscillator
- AORT 93.15
- WT 88.60
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.